Ekso Bionics (NASDAQ:EKSO) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Ekso Bionics (NASDAQ:EKSO) in a research note released on Saturday morning. The firm issued a hold rating on the stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $10.00 price target on shares of Ekso Bionics in a research note on Tuesday, July 30th.

Ekso Bionics Trading Down 15.0 %

EKSO opened at $0.96 on Friday. The stock has a market cap of $17.45 million, a PE ratio of -0.99 and a beta of 1.45. The company has a quick ratio of 1.77, a current ratio of 2.42 and a debt-to-equity ratio of 0.36. Ekso Bionics has a twelve month low of $0.83 and a twelve month high of $3.13. The company has a fifty day moving average of $1.11 and a 200-day moving average of $1.15.

Ekso Bionics (NASDAQ:EKSO) last issued its quarterly earnings results on Monday, October 28th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.02). Ekso Bionics had a negative return on equity of 92.08% and a negative net margin of 68.41%. The business had revenue of $4.13 million for the quarter, compared to analyst estimates of $6.00 million. During the same quarter in the previous year, the business posted ($0.24) earnings per share. On average, sell-side analysts predict that Ekso Bionics will post -0.42 EPS for the current year.

Hedge Funds Weigh In On Ekso Bionics

An institutional investor recently raised its position in Ekso Bionics stock. Kent Lake Capital LLC boosted its position in Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) by 322.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 596,050 shares of the company’s stock after buying an additional 454,892 shares during the period. Kent Lake Capital LLC owned approximately 3.28% of Ekso Bionics worth $811,000 at the end of the most recent quarter. Institutional investors and hedge funds own 6.42% of the company’s stock.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.